method
describ
vitro
studi
viral
humor
immun
respons
pig
oral
immun
transmiss
gastroenter
tge
coronaviru
antibodi
product
prime
mesenter
lymph
node
cell
reveal
vitro
boost
viral
antigen
latter
leukocyt
cocultur
uvinactiv
viru
use
varieti
differ
method
antigen
stimul
enumer
specif
antibodysecret
cell
asc
titrat
secret
antiviru
antibodi
perform
elisaspot
use
carbazol
peroxidas
chromogen
elisa
test
respect
accord
ig
isotyp
result
show
close
relationship
asc
number
secret
antibodi
titr
best
vitro
antibodi
synthesi
observ
sensit
cell
maintain
contact
viru
whole
cultur
period
antibodi
respons
defin
kinet
profil
character
narrow
peak
maximum
occur
day
cultur
iga
respons
appear
earlier
igg
methodolog
analys
specif
antibodi
respons
cellular
level
may
permit
studi
mechan
ig
isotyp
regul
extend
leukocyt
organ
immun
system
may
also
constitut
vitro
model
studi
antibodi
respons
express
differ
lymphoid
tissu
pig
transmiss
gastroenter
tge
highli
contagi
enter
diseas
swine
caus
coronaviru
usual
result
transient
diarrhea
adult
major
caus
death
piglet
two
week
age
bohl
garw
lactogen
immun
induc
sow
natur
infect
oral
immun
appear
import
mechan
protect
newborn
piglet
tge
infect
hooper
haeltermann
bohl
et
al
aynaud
et
al
viral
stimul
gutassoci
lymphoid
tissu
galt
sow
lead
product
mammari
secret
antibodi
secretori
iga
protect
piglet
intestin
mucosa
bohl
et
al
bohl
research
program
mainli
focus
improv
protect
suckhng
piglet
milkborn
immun
although
presenc
secretori
iga
antibodi
milk
link
immun
statu
intestin
mucosa
mechan
regul
local
antibodi
product
still
unclear
enter
tropism
tge
coronaviru
permit
studi
induct
modul
local
iga
respons
order
better
understand
mechan
oper
regul
antigenspecif
iga
product
secretori
immun
system
cellular
level
necessari
establish
vitro
model
antigen
stimul
pig
leukocyt
use
tge
viru
tgev
techniqu
enumer
result
specif
antibodysecret
cell
asc
accord
ig
isotyp
method
use
vitro
antigen
stimul
essenti
develop
studi
vitro
primari
secondari
plaqueform
cell
respons
follow
stimul
pig
blood
mononuclear
cell
mous
red
blood
cell
mrbc
subsequ
also
appli
respons
ovalbumin
ova
binn
berthon
binn
manuscript
prepar
sinc
hemolyt
plaqu
assay
jern
nordin
jern
et
al
appear
appropri
determin
number
specif
asc
respons
pig
leukocyt
cultur
viral
particl
enumer
undertaken
elisaspot
test
although
origin
describ
investig
asc
respond
protein
antigen
ova
czerkinski
et
al
holt
holt
et
al
bianchi
et
al
elisaspot
test
use
viral
antigen
russel
et
al
tge
viru
test
perform
use
virusinfect
swine
testi
st
cell
monolay
antigen
grom
bernard
russel
et
al
cubero
pablo
et
al
carbazol
chromogen
peroxidas
reaction
pauli
et
al
report
describ
method
studi
vitro
antibodi
respons
pig
galt
tge
viru
cellular
level
effect
variou
vitro
antigen
stimul
method
humor
immun
respons
vivo
prime
mesenter
leukocyt
studi
specif
antibodi
product
measur
accord
ig
isotyp
use
two
techniqu
enumer
anticoronaviru
asc
elisaspot
test
titrat
specif
antibodi
secret
cultur
supernat
elisa
test
two
meishan
piglet
oral
infect
virul
gep
ii
strain
tgev
aynaud
et
al
aynaud
et
al
oral
boost
day
slaughter
month
later
x
viral
plaqueform
unit
pfu
vaccin
attenu
nouzilli
strain
aynaud
et
al
aynaud
et
al
nguyen
et
al
b
c
tgev
leukocyt
prepar
piglet
mesenter
lymph
node
mln
describ
previous
salmon
salmon
except
wash
medium
use
eli
medium
elac
medium
flow
laboratori
supplement
yeast
extract
difco
medium
cultur
medium
rpmi
boehring
mannheim
respect
supplement
heatinactiv
normal
pig
serum
np
instead
fetal
calf
serum
fc
cell
viabil
assess
trypan
blue
dye
exclus
test
cell
suspens
adjust
final
concentr
viabl
leukocyt
per
ml
cultur
medium
npsrpmi
medium
highpassag
purdu
strain
bohl
et
al
frederick
bohl
laud
et
al
nguyen
et
al
use
sourc
cultur
viral
antigen
materi
viru
propag
monolay
st
cell
line
mcclurkin
norman
suppli
dr
eh
bohl
wooster
oh
usa
describ
aynaud
et
al
nguyen
et
al
incub
c
h
infect
st
cell
cultur
frozen
c
thaw
cultur
fluid
collect
cell
debri
remov
centrifug
x
g
min
c
infecti
viral
particl
inactiv
short
exposur
uv
light
viral
titer
adjust
equival
pfuml
medium
supemat
uninfect
st
cell
cultur
similarli
treat
use
control
antigen
prepar
store
c
well
tissu
cultur
plate
linbro
flow
laboratori
ml
leukocyt
suspens
x
cellswel
mix
ml
medium
ml
uvinactiv
viru
prepar
pfuwel
cultur
perform
day
everi
day
supemat
sampl
taken
well
ml
first
sampl
ml
other
fresh
cultur
medium
mlwell
ad
control
cultur
antigen
use
ml
uvtreat
supemat
uninfect
st
cell
cultur
control
st
three
method
use
vitro
antigen
stimul
viral
stimul
v
mesenter
leukocyt
normal
mix
viral
antigen
begin
cultur
describ
fresh
cultur
medium
ad
without
puls
viral
stimul
pv
leukocyt
cultur
wash
h
incub
viral
antigen
supemat
replac
fresh
cultur
medium
without
viru
repeat
viral
stimul
rv
antigeni
stimul
protocol
level
antigen
kept
constant
throughout
experi
repeat
addit
viral
antigen
concentr
ml
addit
fresh
cultur
medium
microtit
plate
flatbottom
well
falcon
becton
dickinson
coat
tge
viral
cellular
antigen
follow
st
cell
line
grown
confluenc
well
uniformli
infect
overnight
purdu
strain
tgev
cytopath
effect
occur
infect
cell
cultur
wash
care
cold
phosphatebuff
salin
pb
three
time
fix
min
mlwell
cold
vv
acetonewat
solut
plate
store
c
use
test
antigenco
well
wash
three
time
tap
water
pb
remov
aceton
protein
adhes
well
block
bovin
skim
milk
regilait
francelait
pb
min
follow
two
wash
pb
everi
day
leukocyt
cultur
content
six
eight
well
harvest
cell
wash
eli
medium
supplement
fc
remov
pig
serum
free
antibodi
centrifug
x
g
min
cell
pellet
resuspend
medium
suspens
prepar
contain
lo
viabl
leukocytesml
elisaspot
test
perform
layer
ml
leukocyt
dilut
cultur
sampl
antigenco
well
well
uninfect
st
cell
use
control
plate
centrifug
x
g
min
room
temperatur
incub
h
leukocyt
remov
plate
three
rins
tap
water
three
wash
pb
contain
tween
serva
replac
mlwell
optim
concentr
peroxidaselabel
antiig
either
rabbit
antipig
igg
h
l
chain
polyclon
antibodi
cappel
organon
teknika
franc
mous
antipig
iga
monoclon
antibodi
mab
kindli
suppli
prof
fj
boum
dr
cr
stoke
k
steven
langford
bristol
uk
coval
label
peroxidas
describ
nakan
kawavi
dilut
pb
contain
tween
skim
milk
incub
period
min
c
plate
wash
three
time
tween
enzym
reaction
step
perform
incub
room
temperatur
carbazol
sigma
h
substrat
solut
pauli
et
al
min
secret
antibodi
plaqu
reveal
red
spot
virusinfect
st
cell
monolay
reaction
stop
wash
plate
pb
plate
store
pb
read
number
spot
per
well
count
use
leitzdiavert
invert
microscop
magnif
leukocyt
incub
h
spot
cover
three
st
cell
consid
result
antibodi
secret
overnight
incub
period
size
secret
antibodi
spot
increas
direct
immunoperoxidas
stain
tend
approach
confluenc
make
read
unreli
sinc
assay
perform
pool
six
eight
well
repres
averag
sever
cultur
number
spot
directli
proport
leukocyt
concentr
accur
spot
number
determin
least
two
viabl
cell
dilut
sampl
express
mean
sem
number
virusspecif
spotform
cell
sfc
determin
differ
number
spot
observ
viral
antigenco
well
number
uninfect
st
cellcoat
well
result
express
number
virusspecif
sfc
per
leukocyt
initi
put
cultur
supernat
leukocyt
cultur
analyz
determin
ig
isotyp
tgevspecif
antibodi
elisa
immunocaptur
techniqu
use
briefli
microtit
plate
nunc
immunopl
precoat
mixtur
monoclon
antibodi
specif
structur
protein
tgev
delma
et
al
laud
et
al
dilut
carbon
buffer
ph
c
wash
plate
block
overnight
skim
milk
pb
viral
antigen
bound
well
precoat
plate
incub
supernat
st
cell
cultur
infect
viral
purdu
strain
dilut
pb
contain
tween
skim
milk
h
c
uninfect
st
cell
cultur
supernat
use
control
sampl
contain
unknown
antibodi
ad
dilut
buffer
incub
h
immun
complex
conjug
peroxidaselabel
pig
igg
igm
rabbit
antipig
igg
igm
polyclon
antibodi
bernard
et
al
bernard
lantier
ad
h
c
tgevspecif
iga
antibodi
reveal
purdu
st
cell
monolay
peroxidaseconjug
mab
use
condit
elisaspot
test
enzym
reaction
develop
acid
boehring
mannheim
substrat
solut
read
nm
result
averag
duplic
express
optic
densiti
od
observ
ml
dilut
cultur
supernat
kinet
vitro
antibodi
respons
obtain
mln
cell
differ
anim
similar
differ
magnitud
report
present
data
piglet
magnitud
close
mean
valu
determin
eight
anim
total
igasc
per
leukocyt
igaasc
preliminari
studi
vitro
boost
carri
blood
leukocyt
measur
elisa
test
show
amount
specif
antibodi
secret
cultur
supernat
proport
concentr
viral
antigen
ad
begin
cultur
pfuwel
howev
higher
antigen
concentr
induc
great
increas
detect
od
pfuwel
versu
pfuwel
day
cultur
basi
viral
titer
usual
reach
purdu
strain
st
cell
line
pfuwel
chosen
antigen
concentr
subsequ
experi
mesenter
leukocyt
cultur
continu
stimul
tgev
v
rv
sampl
show
higher
recoveri
live
cell
control
st
puls
stimul
pv
cultur
p
especi
day
durat
cultur
day
fig
cell
cultur
recoveri
pig
mesenter
lymph
node
cell
stimul
vitro
tge
viru
antigen
stimul
carri
day
everi
day
cell
viabil
assess
trypan
blue
dye
exclus
test
cultur
sampl
number
viabl
ceil
express
percentag
mean
valuesd
number
live
cell
initi
put
cultur
cellswel
statist
analys
perform
use
student
test
pair
group
data
repres
triangular
symbol
significantli
differ
p
symbol
squar
n
st
control
ii
pv
puls
viral
stimul
zx
v
viral
stimul
rv
repeat
viral
stimul
see
materi
method
section
cultur
fig
highest
cell
recoveri
obtain
cultur
perform
repeat
addit
viru
rv
though
significantli
differ
normal
stimul
cultur
v
p
thu
vitro
antigen
stimul
seem
induc
cell
prolifer
eg
cell
plasma
blast
vivo
prime
cell
hand
compar
control
puls
antigen
stimul
pv
tend
lead
lower
cell
recoveri
day
cultur
significantli
differ
p
probabl
loss
leukocyt
wash
step
use
remov
free
viral
antigen
comparison
jejun
peyer
patch
mln
shown
latter
import
two
main
organ
lymphoid
tissu
pig
small
intestin
sourc
cell
secret
vitro
antitgev
iga
exampl
day
mln
peyer
patch
cell
cultur
sow
oral
infect
virul
strain
tgev
show
asc
igaasc
asc
igaasc
per
leukocyt
respect
anoth
sow
leukocyt
igaasc
detect
mln
cell
cultur
day
asc
leukocyt
observ
peyer
patch
cell
cultur
studi
vitro
antigen
stimul
method
focus
pig
mesenter
leukocyt
vivo
prime
vitro
boost
asc
reveal
sfc
tgevinfect
cell
monolay
immunoperoxidas
stain
show
secret
antibodi
bound
viral
antigen
express
surfac
membran
cytoplasm
acetonefix
st
cell
antibodi
secret
detect
vivo
prime
leukocyt
cultur
vitro
without
viral
antigen
st
fig
howev
follow
antigen
stimul
kinet
profil
number
tgevspecif
igg
asc
fig
show
quit
narrow
peak
day
cultur
maximum
number
day
cultur
carri
repeat
addit
viru
rv
show
greater
number
antitgev
igg
asc
max
leukocyt
viru
introduc
begin
cultur
v
max
leukocyt
use
h
puls
stimul
pv
peak
igg
respons
low
leukocyt
sfc
disappear
day
cultur
igmsecret
cell
detect
experi
data
shown
profil
chang
number
antitgev
iga
sfc
broadli
similar
igg
respons
lower
level
fig
howev
antigen
stimul
protocol
number
specif
igasecret
cell
reach
maximum
earlier
stage
day
cultur
igg
respons
exposur
viru
day
cultur
pv
induc
poor
iga
respons
cell
day
decreas
rapidli
although
rv
stimul
gener
larger
number
antitgev
iga
sfc
v
stimul
leukocyt
ratio
iga
total
ig
sfc
alter
amount
secret
antigenspecif
antibodi
supernat
mesenter
leuko
tgevspecif
sfc
reveal
purdu
st
cell
monolay
use
polyclon
antipig
ig
monocion
antipig
iga
peroxidaseconjug
antibodi
spot
appear
uninfect
st
cell
result
express
number
antigenspecif
sfc
xsem
per
leukocyt
initi
put
cultur
iggsfc
sinc
igmsecret
cell
detect
result
obtain
differ
number
whole
antitgev
sfc
total
ig
number
tgevspecif
iga
sfc
b
igasfc
abbrevi
fig
cyte
cultur
measur
use
elisa
test
fig
igm
antibodi
found
data
shown
although
detect
day
igg
antitgev
appear
supernat
antigen
stimul
day
cultur
fig
increas
rapidli
reach
maximum
day
largest
igg
antibodi
respons
detect
viru
ad
begin
cell
cultur
v
sampl
rather
viru
ad
repeatedli
rv
sampi
littl
tgevspecif
igg
detect
sampl
cultur
without
viru
st
follow
short
antigen
stimul
pv
profil
iga
respons
vitro
boost
fig
similar
igg
respons
though
highest
level
antibodi
observ
day
cultur
respons
puls
viral
stimul
produc
less
antigenspecif
iga
synthesi
increas
lower
peak
level
high
averag
background
comparison
respons
vitro
shown
count
antitgev
asc
measur
amount
secret
antigenspecif
antibodi
cultur
supernat
show
two
method
gave
similar
result
fig
illustr
data
obtain
normal
viral
stimul
v
sampl
similar
correl
found
respons
follow
form
antigen
stimul
data
shown
ig
isotyp
respons
igg
fig
iga
fig
evolut
antibodi
respons
defin
narrow
peak
case
maximum
titer
secret
antitgev
antibodi
occur
day
maximum
number
specif
antibodyform
cell
moreov
use
elisaspot
elisa
test
iga
respons
tgev
seem
take
place
earlier
igg
respons
two
day
interv
maxima
iga
igg
immun
respons
previou
studi
vitro
immun
respons
pig
leukocyt
tgev
focus
antigeninduc
lymphocyt
prolifer
welch
et
al
product
virusspecif
neutral
antibodi
prime
lymphocyt
cultur
stimul
purifi
tgev
wesley
et
al
compar
last
report
vitro
antigen
stimul
method
permit
use
crude
viral
antigen
prepar
titrat
secret
antitgev
antibodi
without
treatment
cultur
supernat
sampl
sinc
protect
mechan
tge
infect
seem
provid
antitgev
neutral
antibodi
shirai
et
al
wesley
et
al
humor
immun
respons
induc
pig
mln
tgev
studi
estim
total
tgevspecif
antibodyproduc
cell
secret
product
accord
ig
isotyp
regardless
neutral
activ
specif
asc
reveal
elisaspot
techniqu
use
carbazol
chromogen
peroxidas
reaction
pauli
et
al
give
wellcontrast
red
spot
without
background
st
cell
monolay
odianisidin
chromogen
use
russel
et
al
immunoperoxidas
stain
stabl
plate
could
store
week
read
furthermor
chromogen
need
mix
agaros
unlik
paraphenylenediamin
use
peroxidas
reaction
czerkinski
et
al
phosphat
use
alkalin
phosphatas
conjug
holt
holt
et
al
bianchi
et
al
antigen
spectrum
provid
virusinfect
st
cell
probabl
wider
one
present
isol
viral
particl
thu
antitgev
antibodi
bound
infect
cell
monolay
may
recogn
isol
viru
exampl
antibodi
specif
react
virusinfect
cell
may
epitop
either
express
isol
viral
particl
b
hidden
particl
bernard
et
al
manuscript
prepar
sampl
elisa
techniqu
perform
virusinfect
cell
monolay
grom
bernard
cubero
pablo
et
al
may
sensit
elisa
immunocaptur
techniqu
sensit
elisa
techniqu
use
virusinfect
cell
monolay
employ
experi
studi
iga
antibodi
secret
secret
igg
antibodi
could
determin
immunocaptur
assay
result
present
report
show
close
correl
data
obtain
elisaspot
elisa
test
case
kinet
profil
specif
antibodi
product
character
narrow
peak
antitgev
iga
respons
occur
earlier
igg
suggest
vitro
cultur
condit
antigen
stimul
caus
differenti
late
precursor
antibodyform
cell
accord
hypothesi
lower
total
iga
antitgev
antibodi
respons
observ
leukocyt
jejun
peyer
patch
mesenter
cell
could
reflect
differ
cell
content
stage
differenti
although
good
antibodi
respons
induc
unprim
blood
lymphocyt
stimul
vitro
mrbc
ova
binn
berthon
binn
manuscript
prepar
use
cultur
condit
yet
detect
vitro
antibodi
respons
coronaviru
without
preliminari
vivo
immun
leukocyt
observ
agreement
studi
perform
viral
antigen
african
swine
fever
viru
induct
antibodi
secret
cultur
pig
leukocyt
appear
depend
growth
factor
eg
could
provid
supernat
concanavalin
astimul
leukocyt
casal
et
al
transient
antibodi
respons
illustr
peak
kinet
profil
may
indic
antigen
stimuli
caus
select
termin
differenti
prime
precursor
synthes
plasma
cell
cell
death
sfc
detect
day
leukocyt
cultur
contrast
respons
blood
lymphocyt
mrbc
appropri
condit
show
continu
synthesi
antibodi
beyond
time
vitro
antibodi
product
occur
prime
leukocyt
maintain
contact
viru
v
rv
sampl
could
detect
either
elisa
elisaspot
test
day
cultur
asc
free
igg
reveal
cultur
sampl
day
suggest
effect
igsecret
cell
cell
popul
isol
mln
small
amount
free
iga
detect
day
cultur
supernat
absenc
antitgev
igasfc
may
result
spontan
releas
antibodi
eg
lysi
iga
lymphoblast
andor
releas
cytophil
antibodi
h
puls
antigen
stimul
pv
led
much
lower
briefer
immun
respons
thu
cultur
condit
continu
presenc
viral
antigen
seem
necessari
antibodi
respons
unlik
result
obtain
prime
pig
blood
lymphocyt
cultur
vitro
membran
compon
haemophilu
pleuropneumonia
borthwick
et
al
highest
immun
antibodi
respons
observ
puls
antigen
stimul
h
howev
although
bacteri
antigen
cytotox
lymphocyt
persist
contain
lipopolysaccharid
b
cell
mitogen
provid
potent
complex
respons
presenc
viral
antigen
prepar
cell
cultur
also
induc
greater
cell
recoveri
may
result
polyclon
prolifer
sensit
lymphocyt
andor
put
mitogen
activ
coronaviru
highest
number
antitgev
sfc
observ
rv
sampl
perform
repeat
addit
antigen
throughout
cultur
period
small
improv
antibodi
respons
occur
without
increas
virusspecif
iga
total
ig
sfc
ratio
furthermor
repeat
addit
viral
antigen
time
fresh
medium
result
use
larg
amount
antigen
prepar
complex
synthes
antibodi
cultur
supernat
thu
comparison
normal
viral
stimul
v
method
complex
format
rv
protocol
result
decreas
free
secret
antibodi
titer
reveal
elisa
test
reason
normal
viral
stimul
v
method
perform
one
addit
viral
antigen
begin
leukocyt
cultur
method
chosen
subsequ
experi
methodolog
describ
base
vitro
antigen
boost
follow
initi
vivo
immun
extend
leukocyt
organ
pig
immun
system
permit
character
differ
properti
humor
immun
respons
express
differ
lymphoid
tissu
moreov
use
elisaspot
test
provid
addit
data
obtain
elisa
test
use
enzymelink
immunosorb
assay
permit
precis
analysi
antigenspecif
antibodi
respons
studi
mechan
igisotyp
regul
thu
immunomodul
factor
might
act
regul
either
cell
rate
ig
secret
proport
sensit
lymphocyt
secret
antibodi
techniqu
use
enteropathogen
tge
coronaviru
antigen
may
constitut
valuabl
vitro
model
basic
studi
regul
antigenspecif
iga
synthesi
secretori
immun
system
